Conditional Singlet Oxygen Generation through a Bioorthogonal DNA-targeted Tetrazine Reaction

Area of Science:

• Chemical Biology
• Photodynamic Therapy
• Bioorthogonal Chemistry

Background:

• Photodynamic therapy (PDT) faces limitations including lack of specificity and systemic toxicity.
• Developing photosensitizers that are selectively activated within target cells is crucial for improving PDT efficacy.
• Bioorthogonal reactions offer a powerful tool for precise molecular control within biological systems.

Purpose of the Study:

• To develop novel activatable photosensitizers using bioorthogonal chemistry for enhanced photodynamic therapy.
• To achieve simultaneous conditional phototoxicity and specific subcellular localization.
• To demonstrate the potential of these probes for targeted cancer cell death.

Main Methods:

• Design and synthesis of novel halogenated BODIPY-tetrazine probes.
• Utilizing inverse-electron-demand Diels-Alder (IEDDA) bioorthogonal reactions for probe activation.
• Employing ab initio computations to understand the mechanism of singlet oxygen generation.
• Demonstrating selective activation and phototoxicity in cellular nuclei.

Main Results:

• The novel BODIPY-tetrazine probes function as efficient photosensitizers (Φ_Δ ≈0.50) only after undergoing an intracellular IEDDA reaction.
• Ab initio computations revealed that activation modulates decay channels, controlling singlet oxygen (¹O₂) generation.
• The bioorthogonal approach enabled spatial control, with selective activation demonstrated in cellular nuclei.
• Irradiation of activated probes in nuclei induced cancer cell death.

Conclusions:

• Dual biorthogonal, activatable photosensitizers represent a novel strategy to overcome current PDT limitations.
• This approach allows for conditional phototoxicity and precise subcellular targeting.
• The developed probes offer new therapeutic avenues for more effective and safer photodynamic cancer treatment.